Tonix Pharmaceuticals Announces the Enrollment of Completers From the BESTFIT Trial Into a 12-Month Open-Label Extension Study December 10, 2013 • 8:40 AM EST
Tonix Pharmaceuticals to Present at the Oppenheimer Healthcare Conference November 26, 2013 • 8:40 AM EST
Tonix Pharmaceuticals Partners With the American Chronic Pain Association to Help Raise Awareness About Fibromyalgia October 24, 2013 • 8:45 AM EDT
Tonix Pharmaceuticals to Participate in the Women's Healthcare Innovation and Leadership Showcase on October 15, 2013 October 11, 2013 • 9:27 AM EDT
Tonix Pharmaceuticals Initiates Enrollment in Phase 2b BESTFIT Trial of TNX-102 SL in Fibromyalgia Patients September 16, 2013 • 8:01 AM EDT
Tonix Pharmaceuticals to Present at the First Global Life Sciences Conference in Warsaw, Poland on September 17, 2013 September 12, 2013 • 8:00 AM EDT
Tonix Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 9, 2013 September 4, 2013 • 8:00 AM EDT
Tonix Pharmaceuticals Presents Nonclinical Results at the Ninth World Congress on Myofascial Pain Syndrome and Fibromyalgia Syndrome August 19, 2013 • 8:00 AM EDT